Assessment of repurposed compounds against coronaviruses highlights the antiviral broad-spectrum activity of host-targeting iminosugars and confirms the activity of potent directly acting antivirals
The COVID-19 pandemic highlights the need for novel antiviral drug discovery approaches that could dramatically shorten timelines from compound discovery to clinical development. At the beginning of the pandemic, repurposing approaches were at the forefront of early research efforts to screen for an...
主要な著者: | Brun, J, Arman, BY, Hill, ML, Kiappes, JL, Alonzi, DS, Makower, LL, Witt, KD, Gileadi, C, Rangel, V, Dwek, RA, Von Delft, A, Zitzmann, N |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Elsevier
2025
|
類似資料
-
Iminosugar antivirals: the therapeutic sweet spot
著者:: Alonzi, D, 等
出版事項: (2017) -
Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells
著者:: Perera, N, 等
出版事項: (2022) -
Antiviral effects of an iminosugar derivative on flavivirus infections.
著者:: Wu, S, 等
出版事項: (2002) -
Mechanisms of antiviral activity of iminosugars against dengue virus
著者:: Miller, JL, 等
出版事項: (2018) -
Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4
著者:: Warfield, KL, 等
出版事項: (2016)